E. Webb

Cyclophosphamide depletes tumor infiltrating T regulatory cells and combined with anti-PD-1 therapy improves survival in murine neuroblastoma

S. Beers, E. Williams, S. James, 2022, iScience.

Journal Pre-proof Cyclophosphamide depletes tumour infiltrating T regulatory cells and combined with anti-PD-1 therapy improves survival in murine neuroblastoma

S. Beers, E. Williams, S. Lanati, 2022 .

Immune characterization of pre-clinical murine models of neuroblastoma

M. Cragg, S. Beers, M. Ashton-Key, 2020, Scientific Reports.

A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and Tolerability

John C. Dawson, N. Carragher, M. Arends, 2021, Cancer Research.

Loss of the adhesion protein Kindlin-1 stimulates tumor clearance via modulation of Tregs

V. Brunton, M. Frame, A. Serrels, 2022, bioRxiv.

Kindlin-1 regulates IL-6 secretion and modulates the immune environment in breast cancer models

V. Brunton, M. Frame, A. Serrels, 2023, eLife.

Metronomic cyclophosphamide is more effective than a single dose in resistant tumours Cyclophosphamide depletes tumour infiltrating T regulatory cells and combined with anti-PD-1 therapy improves survival in murine neuroblastoma

S. Beers, E. Williams, S. James, 2022, iScience.